Sunday 22 July 2012

Protective Coating Transforms Silk Into A Weapon Against Anthrax And Other Microbes

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Bio-terrorism / Terrorism
Article Date: 25 May 2012 - 0:00 PDT Current ratings for:
Protective Coating Transforms Silk Into A Weapon Against Anthrax And Other Microbes
not yet ratednot yet rated
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a simple, inexpensive dip-and-dry treatment can convert ordinary silk into a fabric that kills disease-causing bacteria - even the armor-coated spores of microbes like anthrax - in minutes.

This new "killer silk" has many potential uses, including make-shift curtains and other protective coatings that protect homes and other buildings in the event of a terrorist attack with anthrax.

Based on an article by Rajesh R. Naik, Ph.D., and colleagues in the journal ACS Applied Materials & Interfaces, the new podcast is available without charge at iTunes and from http://www.acs.org/globalchallenges.

Naik points out in the podcast that in adverse conditions, bacteria of the Bacillus species, which includes anthrax, become dormant spores, enclosing themselves in a tough coating. These spores can survive heat, radiation, antibiotics and harsh environmental conditions, and some have sprung back to life after 250 million years. Certain chemicals - most popular among which are oxidizing agents, including some chlorine compounds - can destroy bacterial spores, and they have been applied to fabrics like cotton, polyester, nylon and Kevlar. These treated fabrics are effective against many bacteria, but less so against spores. The researchers tried a similar coating on silk to see if it could perform better against these hardy microbes.

They developed a chlorinated form of silk, which involves soaking silk in a solution that includes a substance similar to household bleach and letting it dry. Silk treated for just an hour killed essentially all of the E. coli bacteria tested on it within 10 minutes and did similarly well against spores of a close anthrax relative used as a stand-in. "Given the potent bactericidal and sporicidal activity of the chlorinated silk fabrics prepared in this study, silk-Cl materials may find use in a variety of applications," the authors say. Other applications, they add, include purifying water in humanitarian relief efforts and in filters or to mitigate the effects of toxic substances.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Chemical Society. "Protective Coating Transforms Silk Into A Weapon Against Anthrax And Other Microbes." Medical News Today. MediLexicon, Intl., 25 May. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Protective Coating Transforms Silk Into A Weapon Against Anthrax And Other Microbes'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Seeking Out Terrorists With New Crime-Fighting Tools

Main Category: Bio-terrorism / Terrorism
Article Date: 11 Feb 2012 - 0:00 PST Current ratings for:
Seeking Out Terrorists With New Crime-Fighting Tools
not yet ratednot yet rated
Fingerprints, ballistics, DNA analysis and other mainstays of the forensic science toolkit may get a powerful new crime-solving companion as scientists strive to develop technology for "fingerprinting" and tracing the origins of chemical substances that could be used in terrorist attacks and other criminal acts. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

Bethany Halford, C&EN senior editor, focuses on an emerging field known as chemical forensics, where the goal is to use the technology of chemistry to trace weaponized toxic substances and related materials back to their source. A chemical forensic analysis could, for instance, show that ingredients in a terrorist's weapon were produced in a specific factory. Criminal investigators then could check sales records to determine exactly who purchased those ingredients.

The article explains that the research in the field has expanded substantially during the last few years due mainly to funding from the U.S. Department of Homeland Security (DHS) Chemical Forensics Program. With this research, DHS and chemical forensic scientists are sending messages to the public and to would-be terrorists, the article notes. DHS wants the public to know that the agency is preparing for future attacks, and terrorists to be aware that science is preparing to nab them if they do attack.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our bio-terrorism / terrorism section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Chemical Society. "Seeking Out Terrorists With New Crime-Fighting Tools." Medical News Today. MediLexicon, Intl., 11 Feb. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Seeking Out Terrorists With New Crime-Fighting Tools'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Scientists Find The Structure Of A Key 'Gene Silencer' Protein

Main Category: Genetics
Also Included In: Bio-terrorism / Terrorism
Article Date: 30 Apr 2012 - 1:00 PDT Current ratings for:
Scientists Find The Structure Of A Key 'Gene Silencer' Protein
5 stars5 stars
Scientists at The Scripps Research Institute have determined the three-dimensional atomic structure of a human protein that is centrally involved in regulating the activities of cells. Knowing the precise structure of this protein paves the way for scientists to understand a process known as RNA-silencing and to harness it to treat diseases.

"Biologists have known about RNA-silencing for only a decade or so, but it's already clear that there's an enormous untapped potential here for new therapies," said Ian MacRae, an assistant professor at Scripps Research and senior author of the new report.

The new report, which appeared in the journal Science's advance online publication, Science Express, focuses on Argonaute2. This protein can effectively "silence" a gene by intercepting and slicing the gene's RNA transcripts before they are translated into working proteins.

Interception and Destruction of Messages

When a gene that codes for a protein is active in a cell, its information is transcribed from DNA form into lengths of nucleic acid called messenger RNA (mRNA). If all goes well, these coded mRNA signals make their way to the cell's protein-factories, which use them as templates to synthesize new proteins. RNA-silencing, also called RNA interference (RNAi), is the interception and destruction of these messages - and as such, is a powerful and specific regulator of cell activity, as well as a strong defender against viral genes.

The silencing process requires not only an Argonaute protein but also a small length of guide RNA, known as a short-interfering RNA or microRNA. The guide RNA fits into a slot on Argonaute and serves as a target recognition device. Like a coded strip of VelcroTM, it latches onto a specific mRNA target whose sequence is the chemical mirror image, or "complement," of its own - thus bringing Argonaute into contact with its doomed prey.

Argonaute2 is not the only type of human Argonaute protein, but it seems to be the only one capable of destroying target RNA directly. "If the guide RNA is completely complementary to the target RNA, Argonaute2 will cleave the mRNA, and that will elicit the degradation of the fragments and the loss of the genetic message," said Nicole Schirle, the graduate student in MacRae's laboratory who was lead author of the paper.

Aimed at disease-causing genes or even a cell's own overactive guide RNAs, RNA-silencing could be a powerful therapeutic weapon. In principle, one needs only to inject target-specific guide RNAs, and these will link up with Argonaute proteins in cells to find and destroy the target RNAs. Scientists have managed to do this successfully with relatively accessible target cells, such as in the eye. But they have found it difficult to develop guide RNAs that can get from the bloodstream into distant tissues and still function.

"You have to modify the guide RNA, in some way to get it through the blood and into cells, but as soon as you start modifying it, you disrupt its ability to interact with Argonaute," said MacRae. Knowing the precise structure of Argonaute should enable researchers to clear this hurdle by designing better guide RNA.

More Points for Manipulation

Previous structural studies have focused mostly on Argonaute proteins from bacteria and other lower organisms, which have key differences from their human counterparts. Schirle was able to produce the comparatively large and complex human Argonaute2 and to manipulate it into forming crystals for X-ray crystallography analysis - a feat that structural biologists have wanted to achieve for much of the past decade. "It was just excellent and diligent crystallography on her part," said MacRae.

The team's analysis of Argonaute2's structure revealed that it has the same basic set of working parts as bacterial Argonaute proteins, except that they are arranged somewhat differently. Also, key parts of Argonaute2 have extra loops and other structures, not seen on bacterial versions, which may play roles in binding to guide RNA. Finally, Argonaute2 has what appear to be binding sites for additional co-factor proteins that are thought to perform other destructive operations on the target mRNA.

"Basically, this Argonaute protein is more sophisticated than its bacterial cousins; it has more bells and whistles, which give us more points for manipulation. With this structure solved, we no longer need to use the prokaryotic structures to guess at what human Argonaute proteins look like," MacRae said.

He and Schirle and others in the lab now are analyzing the functions of Argonaute2's substructures, as well as looking for ways to design better therapeutic guide RNAs.

"Now with the structural data, we can see what synthetic guide RNAs will work with Argonaute and what won't," MacRae said. "We might even be able to make guide RNAs that can outcompete natural ones."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our genetics section for the latest news on this subject. The research that led to Schirle and MacRae’s new paper, “The Crystal Structure of Human Argonaute2,” was funded by the National Institute of General Medical Sciences, part of the National Institutes of Health.
Scripps Research Institute Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Scripps Research Institute. "Scientists Find The Structure Of A Key 'Gene Silencer' Protein." Medical News Today. MediLexicon, Intl., 30 Apr. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Scientists Find The Structure Of A Key 'Gene Silencer' Protein'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

H5N1 Bird Flu Pandemic Potential Revealed

Featured Article
Academic Journal
Main Category: Bird Flu / Avian Flu
Also Included In: Bio-terrorism / Terrorism
Article Date: 24 Jun 2012 - 0:00 PDT Current ratings for:
H5N1 Bird Flu Pandemic Potential Revealed
3 stars4 stars
Two papers published this week, and one last month, reveal the pandemic potential of H5N1 "bird flu". One identifies four, another identifies five, genetic changes the virus would have to undergo before it could spread easily in humans, and the third paper suggests some of these changes are already evident in circulating strains.

The papers were written last year, but were held back because of international concerns that making such data public would make it easier for terrorists to make bioweapons.

H5N1, or "bird flu", is a subtype of the influenza A virus that can cause illness in humans and many other animals. It has killed tens of millions of birds and spurred the culling of hundreds of millions of others to stop it spreading.

Since 2003, more than half of the 606 cases of human infection of H5N1 reported to the World Health Organization worldwide, have resulted in death. Most of the cases in humans appear to have occurred as a result of contact with infected birds.

So far, H5N1 has not triggered a pandemic in humans because it does not spread easily among mammals, and some scientists believe it never will. To spread easily from one person to another, the virus would have to become airborne, that is develop the ability to spread via tiny droplets that people spray out of their mouths and noses when they cough and sneeze. That is how other flu viruses, like the H1N1, the "swine flu", that caused a mild pandemic in 2009, spread.

Viruses like H5N1 and H1N1 are mutating all the time. If H5N1 were by chance to acquire some of the properties of H1N1 then it would spread more easily in mammals. One way it could do this is by accumulating chance mutations, another way is by swapping genes with other viruses, for instance while co-infecting an intermediate host (genetic "reassortment").

Much of the focus of H5N1 research, amid concerns about the bioterrorism risk, has been to investigate how easy it might be for H5N1 to mutate into a readily transmissible form, and if so, which genes would be involved. This information is useful for surveillance, so researchers know what changes to look out for in emerging strains when assessing pandemic risk.

The papers published this week and last month show that it would take about four or five genetic changes for H5N1 to mutate into a form that might trigger a pandemic in humans, and that some of these mutations have already occurred in nature. Colorized transmission electron micrograph of Avian influenza A H5N1 viruses
Colorized transmission electron micrograph of Avian influenza A H5N1 viruses In Science this week, one paper describes how the virologist Ron Fouchier of Erasmus MC in Rotterdam, the Netherlands, and colleagues, compared the genetic structure of H5N1 with strains of flu that have caused human pandemics and identified some candidate genes.

Fouchier's team inserted the candidate genes one by one into an actual strain of H5N1 that was isolated from an Indonesian patient, and tested the artificially mutated strains in ferrets to see how easily they would spread (ferrets are a popular model for human flu research). They conclude that H5N1 would need just five genetic changes to transform it into a form that could spread easily and start a human pandemic.

(Actually, the "conclusion" of five mutations is not strictly accurate, it is a media shorthand that gives a reasonable gist of a more complicated story. Fouchier's team tested a number of strains and found up to nine mutations in each transmissible strain were relevant, but they all had five mutations in common, so that is how the number five came about. But there is still the possibility that some of the other mutations could play a role.)

Fouchier and colleagues also conclude that the virus could acquire the capacity for airborne transmission between mammals without having to swap genes with another flu virus while co-infecting an intermediate host (that is by accumulation within the strain, without the help of genetic reassortment).

In Nature last month, another paper, from a group led by Yoshihiro Kawaoka of the University of Wisconsin, Madison in the US, and the University of Tokyo in Japan, using a different approach to Fouchier's team, describes how it would take only four genetic changes, to transform the bird flu virus into an airborne strain.

Instead of taking an actual strain of H5N1 and then inserting genes one by one as the Dutch team did, Kawaoka's team created a hybrid strain of the bird flu virus and the already airborne-capable H1N1 "swine flu" virus. (In theory, such a strain could come about via "reassortment" or gene-swapping between viruses).

Then they showed, also using ferrets, that the hybrid, thanks to four delicately balanced mutations, would be able to bind more strongly to cells in mammals and replicate in sufficient quantity to be able to spread via respiratory droplets.

In the other Science paper published this week, researchers (including Kawaoka and Fouchier) led by mathematician Derek Smith of the University of Cambridge in the UK, explain how they investigated the likelihood of the emergence of a pandemic strain of H5N1 and how using surveillance data, they looked for evidence of whether some of the mutations described in the Kawaoka and Fouchier papers have already occurred in nature.

They found that several wild strains of H5N1 are three mutations away from the four described in Kawaoka's paper, and the five in Fouchier's paper. And they also found a few rare cases where the strain is only two mutations away.

Using some clever maths that they developed themselves, Smith and colleagues then created a model to simulate "within-host viral evolution" to study the factors that would increase or decrease the probability that a virus with some of the mutations could evolve the remaining ones after it had infected a mammalian host.

First author Colin Russell of the University of Cambridge, said in a comment reported in a Science News and Analysis article that a virus that is only three mutations away from acquiring the ability to be airborne is "likely" to do so, but there are so many unknowns they couldn't put a figure on it. The paper's main value is that it points others in the right direction:

"These factors, combined with the presence of some of these substitutions in circulating strains, make a virus evolving in nature a potentially serious threat. These results highlight critical areas in which more data are needed for assessing, and potentially averting, this threat," write the authors.

These papers have appeared after months of international debate about whether this information should be made public, and whether the researchers should have done the experiments in the first place.

In December last year, the US National Science Advisory Board for Biosecurity (NSABB) recommended that the Kawaoka and Fouchier studies, because they reveal so much detail about how the mutations could be introduced, should not be published in full. The concern was that the information could be used by terrorists to create a bioweapon, and this risk outweighed the benefits to public health.

Then, a few months later, after examining revised versions of the papers, the NSABB changed its position, and recommended to the US government that the papers be published in full.

In a statement issued at the end of March, the board said although the papers still contain information that could be useful to those who would use it to do harm, the new information they received caused them to change their risk-benefit calculation such that the benefits now outweight the risks.

An expert panel advising the World Health Organization (WHO) had reached a similar conclusion a month earlier.

This cleared the way for Nature to publish the Kawaoka paper last month, and for Science to publish the Fouchier study this month.

In the meantime, while all this was going on, the influenza scientists responded by imposing a moratorium on themselves, effectively halting some types of H5N1 research, and the US government brought in new legislation to control government-funded studies using dangerous pathogens.

After the initial NSABB decision, the Dutch government also sought to restrict publication of Fouchier's paper by insisting he apply for an export licence, which he eventually did and received.

Fouchier said this week, that publishing the work in full gives scientists the best possible chance of fighting future flu pandemics.

"We hope to learn which viruses can cause pandemics and by knowing that we might be able to prevent them by enforcing strict eradication programmes," he told BBC News.

The activities surrounding the publication of these papers have also served to focus attention on what needs to be done to deal more effectively with research that could be misused, the so-called "dual use research of concern" or DURC.

Dr Bruce Alberts, Science's Editor in Chief, said in a statement reported by the BBC that it looks like we need to develop a "comprehensive, international system for assessing DURC". He said such a system should allow people with a need to know to have "selected access" to information that is omitted from a published scientific report.

But Fouchier said he doubts such a system is even workable, never mind appropriate.

"You can't share information with so many people in the field and keep it confidential," he told the BBC.

Fouchier said the general rule should be to make research information freely available, so scientists can build on it.

Written by Catharine Paddock
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our bird flu / avian flu section for the latest news on this subject. "Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets"; Sander Herfst, Eefje J. A. Schrauwen, Martin Linster, Salin Chutinimitkul, Emmie de Wit, Vincent J. Munster, Erin M. Sorrell, Theo M. Bestebroer, David F. Burke, Derek J. Smith, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, and Ron A. M. Fouchier; Science 22 June 2012: 1534-1541; Link to Abstract.
"The Potential for Respiratory Droplet–Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host"Colin A. Russell, Judith M. Fonville, André E. X. Brown, David F. Burke, David L. Smith, Sarah L. James, Sander Herfst, Sander van Boheemen, Martin Linster, Eefje J. Schrauwen, Leah Katzelnick, Ana Mosterín, Thijs Kuiken, Eileen Maher, Gabriele Neumann, Albert D. M. E. Osterhaus, Yoshihiro Kawaoka, Ron A. M. Fouchier, and Derek J. Smith; Science 22 June 2012: 1541-1547; Link to Abstract.
"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets"; Masaki Imai, Tokiko Watanabe, Masato Hatta, Subash C. Das, Makoto Ozawa, Kyoko Shinya, Gongxun Zhong, Anthony Hanson, Hiroaki Katsura, Shinji Watanabe, Chengjun Li, Eiryo Kawakami, Shinya Yamada, Maki Kiso, Yasuo Suzuki, Eileen A. Maher, Gabriele Neumann and Yoshihiro Kawaoka; Nature, published online 2 May, updated online 22 May, 2012; DOI:10.1038/nature10831; Link to Article.
Additional sources: "Public at Last, H5N1 Study Offers Insight Into Virus's Possible Path to Pandemic" News Analysis by Martin Enserink, Science, 22 June 2012; BBC News. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Catharine Paddock PhD. "H5N1 Bird Flu Pandemic Potential Revealed." Medical News Today. MediLexicon, Intl., 24 Jun. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


posted by Giuseppe M on 22 Jun 2012 at 11:46 pm

Despite the incredible fanfare subsequent the publications of the most recent papers on ferrets airborned infected by a chimeric virus, the likelihood of an H5Nx pandemic remains the same as yesterday, a month ago, five years ago. In the meantime, H5N1 continues unabated to infect millions of chickens, ducks and a number of wild birds and an unknown number of domesticated mammals and humans. In Egypt, where civil unrests resulted in huge citizens rallies in very close contacts one to another - poultry outbreaks are out of control for years. On the ground, instead in BSL-? labs, biological experiments are ongoing.

| post followup | alert a moderator |


posted by Dr David Hill on 22 Jun 2012 at 4:38 pm

The recent release of Bird Flu research information, where a few mutations could lead to an airborne pandemic, is a nightmare scenario. In 1997 the pandemic was stopped in its tracks in Hong Kong. The system adopted was not reliant upon a drug cure but that prevention was better than cure dictate. It worked and Ken Shortridge who devised the strategy was given the Asian equivalent of the Nobel Prize in medicine, The Prince Mahidol Award. By doing this Prof. Shortridge stopped a bird flu pandemic starting and which had the propensity to kill millions (the only one ever to prevent the deaths of incalculable numbers). The pandemic premise was, ‘don’t let it start in the first place’. Why therefore it has to be asked has the establishment forgotten the first dictum of good medical health thinking that ‘prevention is better than cure'? For in the future humanity has to adopt the only global strategy that will stop in the greatest human mass killer ever happening.

And why have those who are advocating a drug cure not taken on-board this system that has worked? This question is postulated because the Swine Flu pandemic showed that with reference to the Spanish Flu in 1918 which took up to 100 million lives, that a cure would come too late. In this respect it was not until 7 months 1 week that a vaccine was created and then it had to be manufactured and thereafter distributed to the masses (a logistical nightmare). In the second wave of the Spanish Flu, after the virus had mutated again into a human-to-human killer, it did its worst between week 16 and week 26, some 1 month 1 week before a cure was found for the Swine Flu pandemic. Therefore whatever way we look at it a drug vaccine will come too late to save us, no matter who we are from the president of the United States downwards. Fact not fiction. Indeed Margaret Chan, Director-General of the WHO says that it is only a matter of time not when the killer virus will emerge - may be next week, next month, next year or whenever; but it will happen sometime and such a pandemic according to pandemic researchers is now overdue. Therefore we are living on borrowed time and we have to adopt Prof. Shortridge's strategy for the good of all humanity.

Dr David Hill
Chief Executive
World Innovation Foundation
Huddersfield, United Kingdom/Bern, Switzerland

| post followup | alert a moderator |


'H5N1 Bird Flu Pandemic Potential Revealed'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Coverage Of Terrorist Attacks On TV: Viewing Increases Pain Intensity

Main Category: Bio-terrorism / Terrorism
Also Included In: Pain / Anesthetics;  Public Health
Article Date: 04 Jul 2012 - 0:00 PDT Current ratings for:
Coverage Of Terrorist Attacks On TV: Viewing Increases Pain Intensity
not yet rated1 star
"Exposure to media coverage of terrorist missile attacks increases pain levels in people already suffering from chronic pain," according to a new study by Ben-Gurion University of the Negev (BGU) researchers.

"Does War Hurt? Effects of Media Exposure After Missile Attacks on Chronic Pain," published in the online version of the Journal of Clinical Psychology in Medical Settings, showed that exposure to the attacks through the media predicted an increase in pain intensity and in the sensory component of pain during the pre-post war period, but did not predict depression or anxiety.

These findings contribute to the understanding of the effects of terrorism on physical and emotional distress, and identify chronic pain patients as a vulnerable population requiring special attention during terrorism-related stress.

Prof. Golan Shahar and Dr. Sheera F. Lerman of BGU's Department of Psychology, along with Dr. Zvia Rudich of Soroka University Medical Center, assessed patients regarding their pain, depression and anxiety, as well as their level of exposure following the missile attacks during Operation Cast Lead in Israel's Negev Region. Prof. Shahar is also affiliated with Yale University's Department of Psychiatry in New Haven, Connecticut.

Stress and media exposure were also strongly related, suggesting that the amount of television viewing related to the terrorist attacks may have influenced how much stress the individual experienced.

"Patients' previous levels of emotional distress may affect their ability to cope with stressful situations, making stressors more prominent and influencing them to seek out more information about the situation," Prof. Shahar explains.

The study assessed 55 chronic pain patients treated at a specialty pain clinic. The patients completed self-report questionnaires regarding their pain, depression and anxiety before and after the three-week missile attack.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our bio-terrorism / terrorism section for the latest news on this subject. The research was supported by The Israel Science Foundation (Grant No.751/08).
American Associates, Ben-Gurion University of the Negev Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Associates, Ben-Gurion University of the. "Coverage Of Terrorist Attacks On TV: Viewing Increases Pain Intensity." Medical News Today. MediLexicon, Intl., 4 Jul. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Coverage Of Terrorist Attacks On TV: Viewing Increases Pain Intensity'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Saturday 21 July 2012

Potential To Diagnose Radiation Exposure Using Novel Biomarkers

Main Category: Radiology / Nuclear Medicine
Also Included In: Bio-terrorism / Terrorism;  Aid / Disasters
Article Date: 24 May 2012 - 1:00 PDT Current ratings for:
Potential To Diagnose Radiation Exposure Using Novel Biomarkers
not yet ratednot yet rated
Researchers at the Medical College of Wisconsin have identified novel biomarkers that could be used to confirm exposure to damaging radiation in large groups of people potentially exposed to unknown and variable doses for the purpose of triage and treatment.

The findings are published in Radiation Research. John E. Baker, Ph.D., professor of surgery, biochemistry, pharmacology and toxicology at the Medical College of Wisconsin, is the lead author of the study.

There is an urgent need for rapid, accurate and sensitive diagnostic platforms to confirm exposure to radiation and estimate the dose absorbed by individuals - whether that exposure is a result of radiological terrorism, nuclear power plant accident, or nuclear warfare. Clinical symptoms do not provide adequate diagnostic information to triage and treat life-threatening radiation injuries; furthermore, the United States has been found to be ill-suited to evaluate and triage large groups of patients with potential radiation exposure.

In this study, researchers examined the microbes found in rat feces before and after exposure to radiation. Changes were identified in the levels of 212 genomically distinct bacteria, of which 59 are found in humans. Those changes persisted at least 21 days following the exposure to radiation. One particular type of microbe, Proteobacteria, increased almost one-thousand fold four days following irradiation.

"If there were to be a radiological terrorism scenario, there could be hundreds of thousands of people that would be present around the ground zero area, and limited medical resources available to evaluate their exposure levels," explained Dr. Baker. "Analyzing microbial signatures in those patients would be a non-invasive way to obtain results in a timely fashion, and allow us to commit resources to patients in need of intervention."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our radiology / nuclear medicine section for the latest news on this subject. The study was funded and data generated with US federal funds from the NIH Human Microbiome Project, the Common Fund, National Institute of Allergy and Infectious Diseases grant 1R01AI080363, and from grants from Tricorder Diagnostics and the Foundation for Heart Science.
The PhyloChip™ assay, developed by Second Genome, was utilized in this study to examine specific bacterial taxa.
Other authors of the study include Vy Lam, Ph.D.; John E. Moulder, Ph.D.; Nita H. Salzman, M.D., Ph.D., the Medical College of Wisconsin; and Eric A. Dubinsky, Ph.D.; and Gary L. Andersen, Ph.D.; from Lawrence Berkeley National Laboratory in California. Dr. Andersen has an affiliation with Second Genome. Dr. Baker has an affiliation with Tricorder Diagnostics and the Foundation for Heart Science. The other authors report no such affiliation.
Medical College of Wisconsin Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Medical College of Wisconsin. "Potential To Diagnose Radiation Exposure Using Novel Biomarkers." Medical News Today. MediLexicon, Intl., 24 May. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Potential To Diagnose Radiation Exposure Using Novel Biomarkers'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

New Preventive Treatments Available For Mild HIV

Editor's Choice
Main Category: HIV / AIDS
Also Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 19 Jul 2012 - 12:00 PDT Current ratings for:
New Preventive Treatments Available For Mild HIV
5 stars4 stars
According to researchers from Lund University in Sweden, they have opened the way for new methods to slow the development of AIDS in HIV-1 infected patients. The authors hope that their study, published in New England Journal of Medicine, can improve treatment methods and preventive measures to fight HIV and AIDS.

HIV-1 is the most common type of the virus that causes AIDS, and when it infects someone who already struggles with the milder HIV-2, it is less aggressive. In this study, the experts examined how the disease developed in people infected with HIV-1 and those who were infected with both HIV-1 and HIV-2.

Joakim Esbjörnsson, a virologist at Lund University, said:

"The moderating effect of HIV-2 was extremely strong. The time it took to develop AIDS was around 50 percent longer for those infected with both strains than for those only carrying the HIV-1 virus. The unusually large difference makes me, as a researchers, very optimistic that it will be possible to identify new and significant approaches that can be taken to combating the development of AIDS."

The unique thing about their research, explained Hans Norrgren, researcher at Lund University and Skåne University Hospital and doctor in infectious diseases, is that not only has the investigation been carried out for more than 20 years, but they have also followed healthy people from when they were first infected with HIV-1, or both HIV-1 and HIV-2, through the development of the disease which allowed them to compare how the infection in each individual has progressed over time.

Investigations showed that there was a difference in the genetic diversity of the HIV that was linked to an early stage of HIV infection. During the development of an infection, different strains of HIV co-exist; and the closer to AIDS the infection gets to, the larger the genetic difference between them.

CD4+ T cells, which are helper cells that play a key role in the immune system that are destroyed by the HIV virus, were also examined. Participants infected with both HIV-1 and HIV-2 had an advantage with these cells. In the course of infection, dual infected patients had a higher number of CD4+ T cells making it take longer to reach low levels of those cells. This meant that it would take longer for the infection to develop into AIDS.

Patrick Medstrand, Professor of Virology at Lund University, said:

"Our results suggest that HIV-2 can activate cellular reactions which naturally check the development of AIDS. If we can map these, I think we can also uncover entirely new mechanisms that are key to the slower development of the disease. In the long run, this could lead to better preventive measures and treatments."

A unique 20-year study of 4,700 infected people in Guinea-Bissau in West Africa lies behind the discoveries.

Fredrik Månsson, a doctor in infectious diseases in Malmö and one of the researchers in the study, explained:

"Our work is the result of many people's work over many years, in particular the staff of the National Public Health Laboratory in Guinea-Bissau and the police health station in the capital Bissau, who have carried out the practical work of examining the study participants, taking samples and conducting laboratory analyses."

Like HIV-1, HIV-2 can also lead to AIDS

HIV-2, the milder strain of HIV, is found on a large scale only in West Africa. More people are infected with HIV-1 than HIV-2, and know that it is more aggressive. However, HIV-2 can also lead to AIDS. Fewer people infected with HIV-2 develop AIDS, and only about 25-30 percent of those who have received no treatment.

Written by Sarah Glynn
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our hiv / aids section for the latest news on this subject. Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection
Joakim Esbjörnsson, Ph.D., Fredrik Månsson, M.D., Ph.D., Anders Kvist, Ph.D., Per-Erik Isberg, M.Sc., Salma Nowroozalizadeh, Ph.D., Antonio J. Biague, M.D., Zacarias J. da Silva, M.D., Ph.D., Marianne Jansson, Ph.D., Eva Maria Fenyö, M.D., Ph.D., Hans Norrgren, M.D., Ph.D., and Patrik Medstrand, Ph.D.
New England Journal of Medicine July 2012 doi:367:224-232 Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Sarah Glynn. "New Preventive Treatments Available For Mild HIV." Medical News Today. MediLexicon, Intl., 19 Jul. 2012. Web.
20 Jul. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'New Preventive Treatments Available For Mild HIV'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here